Americans will face a cancer diagnosis in their lifetime
New cancer cases in the U.S. every year
Cancers are identical — even with the same diagnosis
Blood draw is all it takes to begin your personalized protocol
Treatment That Finds the Target
Nanoparticle carriers are engineered to seek out and bind to specific biological targets — cancer cells and their distinct chemistry — rather than circulating everywhere at once.
Opens Only Inside the Cancer Cell
Carriers exploit differences in diseased-cell chemistry, releasing their payload only once inside the target cell — like a Trojan horse that stays sealed everywhere else.
Lower Doses, Less Collateral Damage
Because treatment concentrates where it matters, doses are lower and healthy tissue is spared — most patients experience minimal side effects compared to conventional drugs.
A Repeatable Window Into Your Cancer
A simple blood draw captures circulating tumor cells and tumor DNA — so your team can track what is driving your cancer and how it responds, visit after visit.